STAAR Surgical Company (FRA:SR3)

Market Cap	1.11B
Revenue (ttm)	197.20M
Net Income (ttm)	-82.41M
Shares Out	n/a
EPS (ttm)	-1.67
PE Ratio	n/a
Forward PE	56.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	25
Open	22.37
Previous Close	22.35
Day's Range	22.37 - 22.37
52-Week Range	12.79 - 27.45
Beta	n/a
RSI	47.15
Earnings Date	Feb 17, 2026

About STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors...

• Industry: Ophthalmic Goods
• Founded: 1982
• Employees: 1,157
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SR3

Financial Performance

Financial numbers in USD